Medicare Panel’s Failure to Recommend Payment for New Alzheimer’s Diagnostic Brain Imaging…


Howard Fillit, MD, founding Executive Director and Chief Science Officer of the Alzheimer’s Drug Discovery Foundation and George Vradenburg, Chairman of USAgainstAlzheimer’s today issued a joint statement in response to an advisory opinion last week by the Medicare Evidence Development and Coverage Advisory Committee (MEDCAC) that there is insufficient evidence to support Medicare reimbursement for PET amyloid imaging scans in patients with cognitive impairment being evaluated for Alzheimer’s disease.

Read Release